GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Retained Earnings

Shandong Boan Biotechnology Co (HKSE:06955) Retained Earnings : HK$-690.3 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Shandong Boan Biotechnology Co's retained earnings for the quarter that ended in Dec. 2023 was HK$-690.3 Mil.

Shandong Boan Biotechnology Co's quarterly retained earnings declined from Dec. 2022 (HK$-570.7 Mil) to Jun. 2023 (HK$-694.3 Mil) but then increased from Jun. 2023 (HK$-694.3 Mil) to Dec. 2023 (HK$-690.3 Mil).

Shandong Boan Biotechnology Co's annual retained earnings declined from Dec. 2021 (HK$0.0 Mil) to Dec. 2022 (HK$-570.7 Mil) and declined from Dec. 2022 (HK$-570.7 Mil) to Dec. 2023 (HK$-690.3 Mil).


Shandong Boan Biotechnology Co Retained Earnings Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Retained Earnings Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Retained Earnings
- - -570.71 -690.29

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Retained Earnings Get a 7-Day Free Trial - - -570.71 -694.31 -690.29

Shandong Boan Biotechnology Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Shandong Boan Biotechnology Co  (HKSE:06955) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines